Imatinib mesylate (IM)-induced growth inhibition is associated with production of spliced osteocalcin-mRNA in cell lines
Keywords: Monocyte/macrophage lineage; Osteoblasts; Osteosarcoma cells; Differentiation; Imatinib mesylate; c-KIT; AML1; AML3; Osteocalcin; Splicing variants;